公司資料
Ionis Pharmaceuticals, Inc. 股價、新聞與催化劑
- 股票代碼:
- IONS
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
46.75 USD (+4.26%)
收盤價
最後更新: 2026年9月17日
12.1B USD
市值
股價為何變動
截至 2026年9月17日，IONS 上漲 4.26%，收於 $46.75。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Ionis Pharmaceuticals is an antisense-RNA company with one of the deepest RNA-targeting pipelines in biotech.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, it sits in specialty biotechnology with global partnered reach.
商業模式特徵
The company combines commercial products, royalties, milestones, and a pipeline of partnered and internally developed RNA programs.
生技產業定位
Ionis is a premier RNA-platform name, and its stock tends to react to clinical data, partnership economics, and label expansion.
未來催化劑
- Ionis’s catalysts are olezarsen commercialization, donidalorsen / neurology progress, and broader RNA-targeting pipeline validation. The next update will help show whether the company is moving from promise to a more de-risked stage of execution. Investors will care less about the label than about whether the platform can keep producing credible next steps.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。